Basit öğe kaydını göster

dc.contributor.authorÖzdatlı, Şükran
dc.contributor.authorKaşıkçıoğlu, G.
dc.contributor.authorGöçmen, Emrah
dc.contributor.authorRüzgar, Melih
dc.contributor.authorOmurtag, Gülden Zehra
dc.date.accessioned10.07.201910:49:13
dc.date.accessioned2019-07-10T20:03:19Z
dc.date.available10.07.201910:49:13
dc.date.available2019-07-10T20:03:19Z
dc.date.issued2016en_US
dc.identifier.citationÖzdatlı, Ş., Kaşıkçıoğlu G., Göçmen, E., Rüzgar, M. ve Omurtag, G. (2016). A pilot study on effects of combination usage of curcumin and melatonin on cisplatin treatment. 52nd Congress of the European-Societies-of-Toxicology (EUROTOX) içinde (S132-S133. ss.). Seville, Spain, September 04-07, 2016. https://dx.doi.org/10.1016/j.toxlet.2016.06.1522
dc.identifier.issn0378-4274
dc.identifier.issn1879-3169
dc.identifier.urihttps://dx.doi.org/10.1016/j.toxlet.2016.06.1522
dc.identifier.urihttps://hdl.handle.net/20.500.12511/3849
dc.description52nd Congress of the European-Societies-of-Toxicology (EUROTOX) -- SEP 04-07, 2016 -- Seville, SPAINen_US
dc.descriptionWOS: 000402436700390en_US
dc.description.abstractCisplatin is an antitumor drug widely used in the treatmentof many malignant tumors. And also some studies show thatmelatonin and curcumin have antitumor activity via several mech-anisms including theirs in addition to theirs potent antioxidantactions. This study was performed to evaluate the effect of cur-cumin and melatonin on the cytotoxicity induced by cisplatin inthe human breast cancer cell line (MCF-7). The cells were treatedwith melatonin or cisplatin or curcumin for 24 and 48 h. Cellviability was quantified using the 3-(4,5-dimethyl-2-thiazolyl)-en_US
dc.description.sponsorshipEuropean Society of Toxicologicen_US
dc.language.isoengen_US
dc.publisherElsevier Ireland Ltden_US
dc.rightsinfo:eu-repo/semantics/embargoedAccessen_US
dc.subjectPharmacyen_US
dc.subjectPharmaceutical Toxicologyen_US
dc.titleA pilot study on effects of combination usage of curcumin and melatonin on cisplatin treatmenten_US
dc.typeconferenceObjecten_US
dc.relation.ispartof52nd Congress of the European-Societies-of-Toxicology (EUROTOX)en_US
dc.departmentİstanbul Medipol Üniversitesi, Eczacılık Fakültesi, Eczacılık Meslek Bilimleri Bölümü, Farmasötik Toksikoloji Ana Bilim Dalıen_US
dc.identifier.volume258en_US
dc.identifier.issueSupplement: Sen_US
dc.identifier.startpageS132en_US
dc.identifier.endpageS133en_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.identifier.doi10.1016/j.toxlet.2016.06.1522en_US
dc.identifier.wosqualityQ2en_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster